Pfizer (PFE)
27.72
-0.22 (0.79%)
Upcoming Events
Latest Headlines
Form 4 PFIZER INC For: Mar 15 Filed by: DAMICO JENNIFER B.
March 18, 2024 6:40 PM - SEC Filing
Form 4 PFIZER INC For: Mar 15 Filed by: BOURLA ALBERT
March 18, 2024 6:40 PM - SEC Filing
Pfizer (PFE) to trim its Haleon stake to 24%
March 18, 2024 5:24 AM - StreetInsider
Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%
March 18, 2024 3:09 AM - StreetInsider
Form ARS PFIZER INC For: Dec 31
March 14, 2024 9:13 AM - SEC Filing
Pfizer (PFE) CEO Albert Bourla's 2023 Total Compensation $21.6M, Down from $33M In 2022
March 14, 2024 9:08 AM - StreetInsider
Form DEFA14A PFIZER INC
March 14, 2024 9:08 AM - SEC Filing
Form DEF 14A PFIZER INC For: Apr 25
March 14, 2024 9:05 AM - SEC Filing
Popular stocks with increasing volume: PLTR PYPL SQ FCX INTC BA SOUN COIN BABA PFE
March 14, 2024 4:34 AM - StreetInsider
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
March 13, 2024 4:00 AM - BizWire
Pfizer (PFE) Reports Positive Overall Survival in Phase 3 Trial of ADCETRIS Regimen
March 12, 2024 6:46 AM - StreetInsider
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
March 12, 2024 6:45 AM - BizWire
ViiV Healthcare Announces Interim Data at CROI Indicating Superior Efficacy of Long-Acting Injectable HIV Treatment Cabenuva (Cabotegravir + Rilpivirine) Compared to Daily Oral Therapy in Individuals
March 6, 2024 12:05 PM - BizWire
Form 4 PFIZER INC For: Mar 04 Filed by: BOURLA ALBERT
March 5, 2024 3:56 PM - SEC Filing
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
March 5, 2024 10:00 AM - BizWire
ViiV Healthcare and The American Academy of HIV Medicine Announce Fellowship to Improve HIV Prevention in Key Communities
March 5, 2024 8:48 AM - BizWire
ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses
March 4, 2024 1:50 PM - BizWire
Form 4 PFIZER INC For: Feb 28 Filed by: BOSHOFF CHRISTOFFEL
March 1, 2024 1:29 PM - SEC Filing
Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
February 29, 2024 5:40 PM - BizWire
Pfizer (PFE) Reports Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO
February 29, 2024 8:01 AM - StreetInsider
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
February 29, 2024 8:00 AM - BizWire
Form 4 PFIZER INC For: Feb 28 Filed by: Dolsten Mikael
February 29, 2024 6:54 AM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: SAHNI PAYAL
February 28, 2024 5:26 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: de Germay Alexandre
February 28, 2024 5:25 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: Denton David M
February 28, 2024 5:18 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: MALIK AAMIR
February 28, 2024 5:18 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: JOHNSON RADY A
February 28, 2024 5:18 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: LANKLER DOUGLAS M
February 28, 2024 5:18 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: McDermott Michael
February 28, 2024 5:18 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: Fonseca Lidia
February 28, 2024 5:11 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: SUSMAN SALLY
February 28, 2024 5:11 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: BOSHOFF CHRISTOFFEL
February 28, 2024 5:11 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: BOURLA ALBERT
February 28, 2024 5:11 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: Dolsten Mikael
February 28, 2024 5:11 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: DAMICO JENNIFER B.
February 28, 2024 5:11 PM - SEC Filing
ViiV Healthcare to present data for its next generation of ultra long-acting treatments for HIV
February 28, 2024 10:04 AM - BizWire
Form 4 PFIZER INC For: Feb 23 Filed by: McDermott Michael
February 27, 2024 1:48 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: SUSMAN SALLY
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: SAHNI PAYAL
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: BOURLA ALBERT
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: Dolsten Mikael
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: JOHNSON RADY A
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: DAMICO JENNIFER B.
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: LANKLER DOUGLAS M
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: BOSHOFF CHRISTOFFEL
February 27, 2024 1:44 PM - SEC Filing
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 26, 2024 10:00 AM - BizWire
Pfizer (PFE) Files Mixed Shelf
February 23, 2024 4:40 PM - StreetInsider
Form S-3ASR PFIZER INC
February 23, 2024 4:38 PM - SEC Filing
Form S-8 PFIZER INC
February 23, 2024 4:38 PM - SEC Filing
Popular stocks with increasing volume: PFE RIVN SMCI SQ CVNA WBD PANW MARA ARM
February 23, 2024 2:08 PM - StreetInsider
Pfizer (PFE) stock is a new Buy at Guggenheim
February 23, 2024 5:41 AM - StreetInsider
Guggenheim Starts Pfizer (PFE) at Buy, 'Successful Execution Can Drive Upside'
February 22, 2024 4:10 PM - StreetInsider
Form 10-K PFIZER INC For: Dec 31
February 22, 2024 1:19 PM - SEC Filing
Pfizer (PFE) Announces EU Approval of VELSIPITY
February 21, 2024 10:36 PM - StreetInsider
Everest Medicines' Partner Pfizer Announces European Commission Approves VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
February 21, 2024 7:48 PM - PR NewsWire
Comprehensive study links COVID vaccines to rare but notable adverse effects
February 20, 2024 2:36 PM - StreetInsider
European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
February 19, 2024 7:45 AM - BizWire
Form 4 PFIZER INC For: Feb 14 Filed by: BOURLA ALBERT
February 16, 2024 12:55 PM - SEC Filing
Form 4 PFIZER INC For: Feb 14 Filed by: DAMICO JENNIFER B.
February 16, 2024 12:53 PM - SEC Filing
Form 4 PFIZER INC For: Feb 14 Filed by: JOHNSON RADY A
February 16, 2024 12:52 PM - SEC Filing
Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day
February 15, 2024 10:00 AM - BizWire
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024 8:45 AM - StreetInsider
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
February 14, 2024 8:30 AM - StreetInsider
Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
February 14, 2024 8:00 AM - StreetInsider
Form SC 13G/A PFIZER INC Filed by: VANGUARD GROUP INC
February 13, 2024 6:00 PM - SEC Filing
ViiV Healthcare announces new packaging option now available in the U.S. for Dovato (dolutegravir/lamivudine)
February 6, 2024 6:47 PM - BizWire
Arvinas (ARVN) and Pfizer (PFE) Announce Vepdegestrant Granted FDA Fast Track Designation
February 6, 2024 6:46 AM - StreetInsider
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
February 6, 2024 6:45 AM - StreetInsider
ViiV Healthcare announces new packaging option now available in the U.S. for Dovato (dolutegravir/lamivudine)
February 5, 2024 11:00 AM - BizWire
Breaking Barriers in Cancer Care: The American Cancer Society and Pfizer Announce a $15 Million, Three-Year Initiative to Bridge the Gap in Cancer Care Disparities
February 5, 2024 10:00 AM - BizWire
Pfizer (PFE) PT Lowered to $28 at UBS
January 31, 2024 10:16 AM - StreetInsider
Pfizer (PFE) PT Lowered to $32 at DZ Bank
January 31, 2024 3:43 AM - StreetInsider
Form 8-K PFIZER INC For: Jan 30
January 30, 2024 8:04 AM - SEC Filing
Midday movers: GM advances, Apple declines, and more
January 30, 2024 7:58 AM - StreetInsider
Pfizer fourth-quarter loss shallower than anticipated
January 30, 2024 6:57 AM - StreetInsider
Pfizer posts surprise 4th quarter profit, but key products miss on sales
January 30, 2024 6:51 AM - StreetInsider
Pfizer (PFE) Tops Q4 EPS by 28c, Tops on Revenue; Offers Guidance
January 30, 2024 6:46 AM - StreetInsider
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
January 30, 2024 6:45 AM - BizWire
Form SC 13G/A PFIZER INC Filed by: STATE STREET CORP
January 29, 2024 1:05 PM - SEC Filing
Pfizer (PFE) February weekly option implied volatility elevated into quarter results
January 29, 2024 10:48 AM - StreetInsider
Pfizer (PFE): FDA Revises Letter of Authorization for the Emergency Use Authorization for Paxlovid
January 29, 2024 9:53 AM - StreetInsider
Dow Jones, Nasdaq, S&P 500 weekly preview: FOMC, NFP, Apple, Microsoft and more
January 29, 2024 9:16 AM - StreetInsider
Pfizer (PFE) February weekly 27.50 straddle priced into quarter results
January 29, 2024 4:09 AM - StreetInsider
Pfizer (PFE) Announces EMA Validates Type II Variation Application for PADCEV with KEYTRUDA for First-Line Treatment of Advanced Bladder Cancer
January 26, 2024 12:01 PM - StreetInsider
European Medicines Agency Validates Type II Variation Application for PADCEV™ (enfortumab vedotin) with KEYTRUDA®(pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
January 26, 2024 12:00 PM - PR NewsWire
European Medicines Agency Validates Type II Variation Application for PADCEV® (enfortumab vedotin) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
January 26, 2024 12:00 PM - BizWire
Form SC 13G/A PFIZER INC Filed by: BlackRock Inc.
January 26, 2024 11:53 AM - SEC Filing
Pfizer (PFE) PT Raised to $29 at UBS
January 17, 2024 10:06 AM - StreetInsider
Form 4 PFIZER INC For: Jan 11 Filed by: JOHNSON RADY A
January 12, 2024 4:17 PM - SEC Filing
Form 4 PFIZER INC For: Jan 11 Filed by: DAMICO JENNIFER B.
January 12, 2024 4:17 PM - SEC Filing
Form 4 PFIZER INC For: Jan 11 Filed by: BOURLA ALBERT
January 12, 2024 4:16 PM - SEC Filing
This stock is a new preferred major pharma pick at Citi
January 11, 2024 5:51 PM - StreetInsider
Form 8-K PFIZER INC For: Jan 10
January 10, 2024 4:39 PM - SEC Filing
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
January 10, 2024 4:30 PM - BizWire
Pfizer (PFE) and Genmab (GMAB) Reports TIVDAK sBLA Accepted for Priority Review by FDA
January 9, 2024 6:45 AM - StreetInsider
TIVDAK® Supplemental Biologics License Application Accepted for Priority Review by FDA for Patients with Recurrent or Metastatic Cervical Cancer
January 9, 2024 6:45 AM - BizWire
TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer
January 9, 2024 6:45 AM - StreetInsider
Pfizer (PFE) Announces EU Approval of TALZENNA with XTANDI for Adult Patients with Metastatic Castration-Resistant Prostate Cancer
January 8, 2024 10:58 AM - StreetInsider
European Commission Approves Pfizer’s TALZENNA® in Combination with XTANDI® for Adult Patients with Metastatic Castration-Resistant Prostate Cancer
January 8, 2024 10:35 AM - BizWire
Pfizer (PFE) and Illumina (ILMN) downgraded but Merck (MRK) can deliver, declares TD Cowen
January 4, 2024 2:30 PM - StreetInsider
Popular stocks with increasing volume: JPM SOFI C BABA MSFT PYPL COIN AMC PLTR GOOGL PBR AAL PFE
January 4, 2024 10:46 AM - StreetInsider
TD Cowen Downgrades Pfizer (PFE) to Market Perform
January 4, 2024 5:29 AM - StreetInsider
Popular stocks with increasing volume: PFE CSCO COIN C PLTR RIVN SOFI BAC INTC T
January 3, 2024 9:46 AM - StreetInsider
Popular stocks with increasing volume: PFE C NIO BABA PLTR COIN RIVN T SOFI BAC INTC UBER
January 3, 2024 4:04 AM - StreetInsider
Form 4 PFIZER INC For: Dec 29 Filed by: Quincey James
January 2, 2024 5:50 PM - SEC Filing
Form 4 PFIZER INC For: Dec 29 Filed by: NARAYEN SHANTANU
January 2, 2024 5:50 PM - SEC Filing
Form 4 PFIZER INC For: Dec 29 Filed by: SMITH JAMES C
January 2, 2024 5:50 PM - SEC Filing
Form 4 PFIZER INC For: Dec 29 Filed by: Echevarria Joseph
January 2, 2024 5:50 PM - SEC Filing
Form 4 PFIZER INC For: Dec 29 Filed by: JOHNSON RADY A
January 2, 2024 5:42 PM - SEC Filing
Form 4 PFIZER INC For: Dec 29 Filed by: DAMICO JENNIFER B.
January 2, 2024 5:42 PM - SEC Filing
Form 4 PFIZER INC For: Dec 29 Filed by: BOURLA ALBERT
January 2, 2024 5:42 PM - SEC Filing
Pfizer (PFE) option implied volatility bid as share price up 3%
January 2, 2024 10:25 AM - StreetInsider
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
January 2, 2024 10:00 AM - BizWire
Form 4 PFIZER INC For: Dec 29 Filed by: BOSHOFF CHRISTOFFEL
December 29, 2023 6:05 PM - SEC Filing
Pfizer (PFE), Sanofi (SNY) and Takeda (TAK) to raise prices on over 500 drugs in the US in January - Reuters
December 29, 2023 9:16 AM - StreetInsider
Healthcare a contrarian idea into 2024 - these stocks could see upside
December 26, 2023 9:42 AM - StreetInsider
Form 3 PFIZER INC For: Dec 15 Filed by: de Germay Alexandre
December 21, 2023 4:21 PM - SEC Filing
Full Article List